50 results
8-K
EX-3.1
COGT
Cogent Biosciences Inc
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
Rights.
4.1 Except as otherwise provided herein or as otherwise required by the DGCL, the Series A Preferred Stock shall have no voting rights. However … Stock acquired upon the conversion of shares of Series A Preferred Stock shall be entitled to the same voting rights as each other holder of Common
8-K
EX-3.1
nupkerrc mgvij659jj6
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
x9ga6quj
22 Mar 24
Unregistered Sales of Equity Securities
8:33am
8-K
kswfobc 8c
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
PRER14A
ujlvkqvb
19 Aug 20
Preliminary revised proxy
8:37am
424B5
kprtw
13 Jun 22
Prospectus supplement for primary offering
6:11am
424B5
9u1s7nz g7cs
8 Jun 23
Prospectus supplement for primary offering
4:01pm
8-K
r9ppxmhz
6 Jul 20
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
10:31am
424B5
pngzafv1 vnay9h
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B5
hbh0shb
30 Nov 20
Prospectus supplement for primary offering
5:28pm
424B5
fnlgqh87et47zjpmj
6 Jun 23
Prospectus supplement for primary offering
5:22pm
424B5
wsx0rw6
15 Jun 22
Prospectus supplement for primary offering
5:16pm